Cynthia Levy

机构：University of Miami, University of Miami Health System · ORCID：0000-0001-5498-6037

发表论文 413 篇 · 总被引 10631 次 · h-index 53

代表论文

• Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 23)
• Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitis (2025 · Journal of Hepatology · 被引 14)
• Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 11)
• Bitopertin shows efficacy in patients with erythropoietic protoporphyria: Results from the randomized, double-blind, placebo-controlled AURORA trial (2025 · Journal of the American Academy of Dermatology · 被引 4)
• O8 Linerixibat significantly improves cholestatic pruritus in primary biliary cholangitis (PBC): results of the pivotal phase 3 GLISTEN trial (2025 · 被引 2)
• P30 Treatment with elafibranor has no impact on bone health in patients with primary biliary cholangitis (PBC) (2025 · 被引 1)